FDA Inspection 1067530 - Avista Pharma Solutions, Inc. dba Cambrex - September 05, 2018

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Avista Pharma Solutions, Inc. dba Cambrex, with an inspection on September 5, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Avista Pharma Solutions, Inc. dba Cambrex
Inspection Date: September 5, 2018
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · d175dd6d-7561-482d-b246-920920a41ec5